According to a new report by MarketsandMarkets™, the Organ-On-Chip Market is set to skyrocket from USD 123,285 thousand in 2024 to USD 631,073 thousand by 2029, growing at an impressive CAGR of 38.6%!
📊 Key Insights:
- Market Size: The market is projected to grow significantly by 2029.
- Organ Types Covered: Liver, Kidney, Intestine, Lung, Heart, and more.
- Products & Services: Includes Instruments, Consumables, Software, and Standard & Custom Services.
- Applications: Focus on Toxicology, Drug Discovery, and Stem Cell Research.
📘 Explore the Full Report: Download PDF Brochure
📈 Comprehensive Data:
- 396 Market Data Tables
- 38 Figures
- 353 Pages of In-depth Analysis
Top Players in the Market:
- MIMETAS B.V. (Netherlands)
- TissUse GmbH (Germany)
- Netri (France)
- Emulate, Inc. (US)
- CN Bio Innovations Ltd (UK)
- Insphero AG (Switzerland)
- SynVivo, Inc. (US)
🔗 Strategies for Growth:
- Mergers & Acquisitions
- Investments & Expansions
- Partnerships & Collaborations
- New Product Developments
Market Segmentation Highlights:
- Model Types: Organ-based and Disease-based models, with the latter showing the highest growth in 2023.
- Organ Types: Liver-on-chip leads the market growth due to its focus on animal-free drug discovery and preclinical research.
- Geographical Insights: Europe stands as the second-largest market, driven by advancements in biofabrication technology and AI in drug discovery.
Recent Industry Developments:
- September 2023: CN Bio Innovations Ltd (UK) partners with LifeNet Health LifeSciences (US) to provide validated human cells for CN Bio’s systems.
- June 2023: TissUse GmbH (Germany) collaborates with PMI (US) to combine PMI’s InHALES technology with TissUse’s Multi-Organ-Chip (MOC) platform.
Market Drivers:
- Increasing government initiatives to reduce animal testing
- Advancements in biofabrication technologies
- Growing acceptance of organ-on-chip technology in pharma and biotech industries
Challenges:
- Technical complexities of organ-on-chip models
- Low throughput of current technologies
Stay ahead of the curve with these exciting developments in the Organ-On-Chip market! 🚀📊
